… maintained its Neutral rating on Geron Corporation (NASDAQ:GERN) after the company … by about one-third. When Geron Corporation (NASDAQ:GERN) made this announcement … H.C. Wainwright noted that Geron Corporation (NASDAQ:GERN) expects its operating …

… Medicines Corporation, Bristol Myers Squibb, Costco, Eisai, Freedom Pay Inc, Genentech, Geron … Care Service Corporation, Hologic, Integrative Emergency Services, Ipsen, Jazz Pharmaceuticals, Johnson …

Summary Geron remains a Sell as RYTELO … ;DigitalVision via Getty Images Introduction Geron’s stock (GERN) has … in May. Recall that Geron markets RYTELO in myelodysplastic syndrome … stocks by evaluating clinical data, treatment guidelines, and market dynamics. …

… , 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial … to continued employment with Geron through the applicable vesting … under the plan. About Geron Geron is a commercial-stage … European Union for the treatment of certain adult patients …

… multiple myeloma, aiming to simplify treatment while maintaining effectiveness. The therapy … option,” said Dr. Joseph Eid, Geron’s executive vice president of … respond to standard erythropoietin-based treatments. Understanding Your Early-Stage Lymphoma …

… Geron, as well as updates from Rhythm Pharmaceuticals and Centessa Pharmaceuticals … relutrigine, as a potential treatment for a group of … — Ben Fidler Rhythm Pharmaceuticals will advance its drug … with developers like Takeda Pharmaceutical and Alkermes to …

… lymphoma who have failed treatment with or relapsed … end of the year. Geron will reduce its workforce … after 36 weeks of treatment. The Advisory Committee on … treatment combo improved outcomes in relapsed/refractory myeloma. Veterinary compounding pharmacy …

… executive roster throughout 2025—Geron Corporation is scaling back its … and $260 million. The pharma noted that it expects … myelofibrosis. Semerjian added that Geron is also “exploring opportunities … the way out at Geron. Geron immediately tapped a replacement …

… 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial- … European Union for the treatment of certain adult … Geron is successful in commercializing RYTELO (imetelstat) for the treatment … efficacy results of RYTELO treatment cause its benefit- …